VYNE
#4591
VYNE Therapeutics Inc. - Common Stock
0.6 6 USD
+0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.13%
Monthly Change
+1.54%
6 month change
+17.86%
Year Change
-50.00%
Previous Close
0.6 4
Open
0.6 6
Low
0.6 6
High
0.6 6
Volume
2
Financials
- Market Capitalization 22.01 M
- Employee 10
- Founded 2003
- CEO N/A
- Website www.vynetherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00H5W8GM8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.94
Price to sales ratio
43.53
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4570 |  SKYE Skye Bioscience, Inc. - Common Stock | 0.66 USD | -4.35% | -5.71% | -16.46% | -17.50% | 23.19 M USD | ||
| 4590 |  ALGS Aligos Therapeutics, Inc. - Common stock | 6.36 USD | -3.93% | +7.61% | +20.00% | -35.04% | 22.03 M USD | ||
| 4592 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.59 USD | +0.22% | +3.90% | -6.66% | +132.31% | 22.00 M USD | ||
| 4593 |  CELU Celularity Inc. - Class A Common Stock | 0.76 USD | +2.70% | 0.00% | -5.00% | -68.60% | 22.00 M USD |
Frequently asked questions about VYNE Therapeutics Inc. - Common Stock
What is the VYNE Therapeutics Inc. - Common Stock stock price today?
The current price of VYNE Therapeutics Inc. - Common Stock (VYNE) is 0.66. Over the past 24 hours, the stock has changed by +3.13%. Follow the VYNE chart for real-time price dynamics.
What is the stock ticker of VYNE Therapeutics Inc. - Common Stock?
VYNE Therapeutics Inc. - Common Stock trades under the ticker VYNE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is VYNE Therapeutics Inc. - Common Stock stock going up?
VYNE has changed by 0.00% over the last week, +1.54% over the last month, and -50.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was VYNE Therapeutics Inc. - Common Stock net income for the last quarter?
VYNE Therapeutics Inc. - Common Stock reported net income of -3.58 M for the last quarter. The previous quarter showed 7.55 M, which means net income changed by -147.48%.
How many employees does VYNE Therapeutics Inc. - Common Stock have?
As of the latest available data, VYNE Therapeutics Inc. - Common Stock has 10 employees. Workforce size can provide additional context about the company's scale and operations.
What is VYNE Therapeutics Inc. - Common Stock EBITDA?
VYNE Therapeutics Inc. - Common Stock EBITDA is -3.81 M, and its EBITDA margin is -4 430.23%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy VYNE Therapeutics Inc. - Common Stock stock?
You can buy VYNE Therapeutics Inc. - Common Stock (VYNE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in VYNE Therapeutics Inc. - Common Stock stock?
Investing in VYNE Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VYNE chart and related analysis on metatrader.com as part of your research.